Celgene Corporation - Strategy and SWOT Report

Oct 7, 2014 - MarketLine - 50 pages - USD $175
Abstract Table of Contents Request Details Related
Celgene Corporation - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360deg view of the company.

Report Features
  • Detailed information on Celgene Corporation required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Celgene Corporation in the form of a SWOT analysis
  • An in-depth view of the business model of Celgene Corporation including a breakdown and examination of key business segments
  • Intelligence on Celgene Corporation's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Celgene Corporation, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Report Highlights

Celgene (or 'the company'), an integrated biopharmaceutical company, is engaged in the research, development and marketing of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. The company operates in the US, Europe and Asia Pacific. It is headquartered in Summit, New Jersey, and employed 4,700 people as of December 31, 2012. The company recorded revenues of $5,506.7 million during the financial year ended December 2012 (FY2012), an increase of 13.7% over FY2011. The operating profit of the company was $1,746.4 million in FY2012, an increase of 21% over FY2011. The net profit was $1,456.2 million in FY2012, an increase of 10.5% over FY2011.

Reasons to Get this Report
  • Gain understanding of Celgene Corporation and the factors that influence its strategies
  • Track strategic initiatives of the company and latest corporate news and actions
  • Assess Celgene Corporation as a prospective partner, vendor or supplier
  • Support sales activities by understanding your customers' businesses better
  • Stay up to date on Celgene Corporation's business structure, strategy and prospects

Order This Report
FORMAT: PDF $175 USD
LICENSE: Single-User
DELIVERY: Instant Download

EASY ORDERING
Once you’ve found the right report, click ‘order now’ and complete the checkout process using any major credit card, check or wire/bank transfer.

Need multi-user or enterprise license pricing? Contact us for a custom quote!
MC, Visa, AMEX, Diners, Discovery, JCB

The Fast Market Research Advantage
Only the Best
All of our research is sourced from the most trusted and established global analysts and consultancies

Client Focused
From start-ups to multinationals, we focus on providing the right research to our diverse client base

Shop Securely
Our US-based customer service team and eCommerce systems adhere to highest data security standards

Industry-leading Customer Support
Individualized assistance from our expert staff is never more than an email or phone call away


About the Publisher
MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. MarketLine is wholly owned subsidiary of Datamonitor.